-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2020 to Q3 2025.
- Tg Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 161M shares, a 0.18% increase year-over-year.
- Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 160M shares, a 7.96% increase from 2023.
- Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 149M shares, a 9.67% increase from 2022.
- Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 135M shares, a 2.41% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)